Ali Saffaei

InstitutionShahid beheshti university of medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 4 publications in June 2020
    All Publications
    Bar chart showing 24 publications over 8 distinct years, with a maximum of 12 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shabani M, Totonchi M, Rezaeimirghaed O, Gachkar L, Hajiesmaeili M, Khoshkar A, Amirdosara M, Saffaei A, Shokouhi S, Mardani M, Alavi Darazam I, Karami A, Sharifi M, Zaman M, Abedheydari E, Sahraei Z. Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19. Pulm Pharmacol Ther. 2021 10; 70:102069. PMID: 34389507.
      Citations:    Fields:    Translation:Humans
    2. Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, Moniri A, Abtahian Z, Haseli S, Mortaz E, Dastan A, Mohamadnia A, Vahedi A, Monjazebi F, Yassari F, Fadaeizadeh L, Saffaei A, Dastan F. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947. PMID: 33607104.
      Citations: 12     Fields:    Translation:Humans
    3. Tabarsi P, Barati S, Jamaati H, Haseli S, Marjani M, Moniri A, Abtahian Z, Dastan A, Yousefian S, Eskandari R, Saffaei A, Monjazebi F, Vahedi A, Dastan F. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205. PMID: 33214093.
      Citations: 18     Fields:    Translation:Humans
    4. Dastan F, Saffaei A, Haseli S, Marjani M, Moniri A, Abtahian Z, Abedini A, Kiani A, Seifi S, Jammati H, Hashemian SMR, Pourabdollah Toutkaboni M, Eslaminejad A, Heshmatnia J, Sadeghi M, Nadji SA, Dastan A, Baghaei P, Varahram M, Yousefian S, Salamzadeh J, Tabarsi P. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869. PMID: 32889241.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    5. Ahmadi ZH, Jahangirifard A, Farzanegan B, Tabarsi P, Abtahian Z, Abedini A, Sharifi M, Jadbabaei AN, Mafhumi Y, Moslem A, Sistani M, Yousefian S, Saffaei A, Dastan F. Extracorporeal membrane oxygenation and COVID-19: The causes of failure. J Card Surg. 2020 Oct; 35(10):2838-2843. PMID: 32678961.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    6. Abtahi-Naeini B, Saffaei A. COVID-19 and elective cosmetic procedures: Asymptomatic transmission in epidemic area and subsequent burdens. J Cosmet Dermatol. 2020 Aug; 19(8):1838-1839. PMID: 32562327.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    7. Shabani M, Shokouhi S, Moradi O, Saffaei A, Sahraei Z. Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion. J Med Virol. 2021 01; 93(1):69-70. PMID: 32492210.
      Citations: 3     Fields:    Translation:Humans
    8. Dastan F, Nadji SA, Saffaei A, Marjani M, Moniri A, Jamaati H, Hashemian SM, Baghaei P, Abedini A, Varahram M, Yousefian S, Tabarsi P. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688. PMID: 32544867.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    9. Dastan F, Nadji SA, Saffaei A, Tabarsi P. Tocilizumab administration in a refractory case of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106043. PMID: 32502524.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    10. Dastan F, Abedini A, Shahabi S, Kiani A, Saffaei A, Zare A. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung. Iran J Allergy Asthma Immunol. 2020 May 17; 19(S1):10-12. PMID: 32534505.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    11. Dastan F, Saffaei A, Mortazavi SM, Jamaati H, Adnani N, Samiee Roudi S, Kiani A, Abedini A, Hashemian SM. Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. J Glob Antimicrob Resist. 2020 06; 21:340-341. PMID: 32353526.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    12. Sahraei Z, Shabani M, Shokouhi S, Saffaei A. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. Int J Antimicrob Agents. 2020 04; 55(4):105945. PMID: 32194152.
      Citations: 82     Fields:    Translation:HumansCellsPHPublic Health
    13. Dastan F, Tabarsi P, Marjani M, Moniri A, Hashemian SMR, Tavakoli-Ardakani M, Saffaei A. Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces. Iran J Pharm Res. 2020; 19(1):1-2. PMID: 32922463.
      Citations: 6     
    14. Jamaati H, Dastan F, Tabarsi P, Marjani M, Saffaei A, Hashemian SM. A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol. Iran J Pharm Res. 2020; 19(1):31-36. PMID: 32922466.
      Citations: 15     
    Saffaei's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (80)
    Explore
    _
    Co-Authors (68)
    Explore
    _
    Similar People (60)
    Explore
    _